Literature DB >> 27982292

2 nd Brazilian Consensus on Chagas Disease, 2015.

João Carlos Pinto Dias1, Alberto Novaes Ramos2, Eliane Dias Gontijo3, Alejandro Luquetti4, Maria Aparecida Shikanai-Yasuda5, José Rodrigues Coura6, Rosália Morais Torres3, José Renan da Cunha Melo3, Eros Antonio de Almeida7, Wilson de Oliveira8, Antônio Carlos Silveira9, Joffre Marcondes de Rezende10, Fabiane Scalabrini Pinto11, Antonio Walter Ferreira12, Anis Rassi13, Abílio Augusto Fragata14, Andréa Silvestre de Sousa15, Dalmo Correia16, Ana Maria Jansen6, Glaucia Manzan Queiroz Andrade3, Constança Felícia De Paoli de Carvalho Britto6, Ana Yecê das Neves Pinto17, Anis Rassi13, Dayse Elisabeth Campos18, Fernando Abad-Franch1, Silvana Eloi Santos3, Egler Chiari19, Alejandro Marcel Hasslocher-Moreno15, Eliane Furtado Moreira20, Divina Seila de Oliveira Marques21, Eliane Lages Silva22, José Antonio Marin-Neto23, Lúcia Maria da Cunha Galvão19, Sergio Salles Xavier24, Sebastião Aldo da Silva Valente17, Noêmia Barbosa Carvalho25, Alessandra Viana Cardoso26, Rafaella Albuquerque E Silva26, Veruska Maia da Costa26, Simone Monzani Vivaldini26, Suelene Mamede Oliveira27, Vera da Costa Valente17, Mayara Maia Lima26, Renato Vieira Alves26.   

Abstract

Chagas disease is a neglected chronic condition with a high burden of morbidity and mortality. It has considerable psychological, social, and economic impacts. The disease represents a significant public health issue in Brazil, with different regional patterns. This document presents the evidence that resulted in the Brazilian Consensus on Chagas Disease. The objective was to review and standardize strategies for diagnosis, treatment, prevention, and control of Chagas disease in the country, based on the available scientific evidence. The consensus is based on the articulation and strategic contribution of renowned Brazilian experts with knowledge and experience on various aspects of the disease. It is the result of a close collaboration between the Brazilian Society of Tropical Medicine and the Ministry of Health. It is hoped that this document will strengthen the development of integrated actions against Chagas disease in the country, focusing on epidemiology, management, comprehensive care (including families and communities), communication, information, education, and research .

Entities:  

Mesh:

Year:  2016        PMID: 27982292     DOI: 10.1590/0037-8682-0505-2016

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  86 in total

Review 1.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

2.  T-Cell Immunophenotyping and Cytokine Production Analysis in Patients with Chagas Disease 4 Years after Benznidazole Treatment.

Authors:  Mauricio Llaguno; Marcos Vinicius da Silva; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Valdo Jose Dias da Silva; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  Severe immune thrombocytopaenia in a patient taking benznidazole for chronic Chagas disease.

Authors:  Clara Crespillo-Andújar; María Calbacho Robles; Francesca F Norman; Jose A Pérez-Molina
Journal:  BMJ Case Rep       Date:  2018-03-27

4.  Pregnancy and Chagas Disease: Benznidazole's Impact on Pregnancy and Newborns: A Report of Four Cases.

Authors:  Cristina Vázquez; Elisa García-Vázquez; Bartolomé Carrilero; Marina Simón; Fuensanta Franco; Maria A Iborra; Luis J Gil-Gallardo; Manuel Segovia
Journal:  Am J Trop Med Hyg       Date:  2020-05       Impact factor: 2.345

5.  Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial.

Authors:  Mayara da Costa Chambela; Mauro Felippe Felix Mediano; Fernanda Martins Carneiro; Roberto Rodrigues Ferreira; Mariana Caldas Waghabi; Verônica Gonçalves Mendes; Luciano de Souza Oliveira; Marcelo Teixeira de Holanda; Andréa Silvestre de Sousa; Andréa Rodrigues da Costa; Sérgio Salles Xavier; Gilberto Marcelo Sperandio da Silva; Roberto Magalhães Saraiva
Journal:  Br J Clin Pharmacol       Date:  2019-11-27       Impact factor: 4.335

6.  Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.

Authors:  Faustino Torrico; Joaquim Gascon; Lourdes Ortiz; Cristina Alonso-Vega; María-Jesús Pinazo; Alejandro Schijman; Igor C Almeida; Fabiana Alves; Nathalie Strub-Wourgaft; Isabela Ribeiro
Journal:  Lancet Infect Dis       Date:  2018-01-16       Impact factor: 25.071

7.  Serological Tests in Chagas Disease: Another Enigmatic Evidence in a Disease Largely Neglected.

Authors:  André Schmidt; José Antonio Marin Neto
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

8.  Correlation between Cardiomegaly on Chest X-Ray and Left Ventricular Diameter on Echocardiography in Patients with Chagas Disease.

Authors:  Matheus Rassi Fernandes Ramos; Henrique Turin Moreira; Gustavo Jardim Volpe; Minna Romano; Benedito Carlos Maciel; André Schmidt; Anis Rassi Junior; Jose Antônio Marin Neto
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

9.  Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of Trypanosoma cruzi-Seropositive Individuals.

Authors:  Maria Carmo P Nunes; Lewis F Buss; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino; Jose Luiz P Silva; Larissa Natany A Martins; Claudia Di Lorenzo Oliveira; Clareci Silva Cardoso; Bruno Oliveira de Figueiredo Brito; Ariela Mota Ferreira; Lea Campos Oliveira; Ana Luiza Bierrenbach; Fabio Fernandes; Michael P Busch; Viviane Tiemi Hotta; Luiz Mario Baptista Martinelli; Maria Carolina F Almeida Soeiro; Adriana Brentegani; Vera M C Salemi; Marcia M Menezes
Journal:  Circulation       Date:  2021-09-27       Impact factor: 29.690

Review 10.  Sirtuin Control of Mitochondrial Dysfunction, Oxidative Stress, and Inflammation in Chagas Disease Models.

Authors:  Xianxiu Wan; Nisha Jain Garg
Journal:  Front Cell Infect Microbiol       Date:  2021-06-09       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.